<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-antioxidants-09-01191">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy</article-title>
  <source>J. Mol. Endocrinol.</source>
  <year>2018</year>
  <volume>60</volume>
  <fpage>145</fpage>
  <lpage>157</lpage>
  <pub-id pub-id-type="doi">10.1530/JME-17-0260</pub-id>
  <pub-id pub-id-type="pmid">29273684</pub-id>
 </element-citation>
</ref>
